Voelz Kerstin, Lammas David A, May Robin C
University of Birmingham, Edgbaston, United Kingdom.
Infect Immun. 2009 Aug;77(8):3450-7. doi: 10.1128/IAI.00297-09. Epub 2009 Jun 1.
The pathogenic yeast Cryptococcus neoformans and C. gattii commonly cause severe infections of the central nervous system in patients with impaired immunity but also increasingly in immunocompetent individuals. Cryptococcus is phagocytosed by macrophages but can then survive and proliferate within the phagosomes of these infected host cells. Moreover, Cryptococcus is able to escape into the extracellular environment via a recently discovered nonlytic mechanism (termed expulsion or extrusion). Although it is well established that the host's cytokine profile dramatically affects the outcome of cryptococcal disease, the molecular basis for this effect is unclear. Here, we report a systematic analysis of the influence of Th1, Th2, and Th17 cytokines on the outcome of the interaction between macrophages and cryptococci. We show that Th1 and Th17 cytokines activate, whereas Th2 cytokines inhibit, anticryptococcal functions. Intracellular yeast proliferation was significantly lower after treatment with the Th1 cytokines gamma interferon and tumor necrosis factor alpha and the Th17 cytokine interleukin-17 (IL-17). Interestingly, however, the Th2 cytokines IL-4 and IL-13 significantly increased intracellular yeast proliferation while reducing the occurrence of pathogen expulsion. These results help explain the observed poor prognosis associated with the Th2 cytokine profile (e.g., in human immunodeficiency virus-infected patients).
致病性酵母新型隐球菌和格特隐球菌通常会在免疫功能受损的患者中引发严重的中枢神经系统感染,但在免疫功能正常的个体中也越来越常见。隐球菌会被巨噬细胞吞噬,但随后能够在这些受感染宿主细胞的吞噬体内存活并增殖。此外,隐球菌能够通过一种最近发现的非裂解机制(称为排出或挤出)逃逸到细胞外环境中。尽管宿主的细胞因子谱会显著影响隐球菌病的结局这一点已得到充分证实,但这种影响的分子基础尚不清楚。在此,我们报告了对Th1、Th2和Th17细胞因子对巨噬细胞与隐球菌相互作用结局的影响的系统分析。我们发现Th1和Th17细胞因子激活抗隐球菌功能,而Th2细胞因子则抑制该功能。在用Th1细胞因子γ干扰素和肿瘤坏死因子α以及Th17细胞因子白细胞介素-17(IL-17)处理后,细胞内酵母增殖显著降低。然而,有趣的是,Th2细胞因子IL-4和IL-13显著增加了细胞内酵母增殖,同时减少了病原体排出的发生。这些结果有助于解释观察到的与Th2细胞因子谱相关的不良预后(例如,在人类免疫缺陷病毒感染患者中)。